Objective: The objective of this study was to evaluate the haemorrhage risk of known and unknown cerebral arteriovenous malformations and their obstetric management. Methods: A retrospective review was performed and analysed 67 consecutive cases of arteriovenous malformation with pregnancy history. Results: Sixty-seven cases of arteriovenous malformation with pregnancy histories were identified. In 14 cases (20.9%) of arteriovenous malformation diagnosed before pregnancy, 11 cases were treated (10 embolisation and one surgery), there was no haemorrhage in 14 pregnancies, 14 healthy babies were delivered by caesarean section in 12 pregnancies (85.7%) and vaginal delivery in two pregnancies (14.3%). In 53 cases (89.1%) of arteriovenous malformation diagnosed during/after pregnancy, there was one (1.6%) case of subarachnoid haemorrhage at 38 weeks' gestation in 64 pregnancies, 64 healthy babies were delivered by caesarean section in 11 pregnancies (17.2%) and vaginal delivery in 53 pregnancies (82.8%). This resulted in 1.6% (95% confidence interval 0-4.6%) haemorrhage rate per pregnancy in unknown arteriovenous malformations. Known arteriovenous malformation gravida was prone to caesarean section; however, vaginal delivery did not increase the haemorrhage risk in unknown arteriovenous malformation gravidas (1.8% vs. 0%, P ¼ 1.000). Conclusion: Prior treatment for ruptured arteriovenous malformation could prevent its haemorrhage during pregnancy and the haemorrhage risk of unruptured arteriovenous malformation in pregnancies is low. Although known arteriovenous malformation gravida is prone to caesarean section, vaginal delivery seems not to increase the haemorrhage risk in unknown arteriovenous malformation gravidas.
Introduction
Most cerebral arteriovenous malformations (AVMs) present with symptoms before 40 years of age, which is the age of pregnancy for women. 1, 2 Pregnancy coexisting with AVM faces every female AVM patient and their families. This problem has not been solved and should be taken into account in different scenarios of preexisting and maternal AVMs. 3 A review of the literature by neurosurgeons once counted the number of past cases of pregnancy-related haemorrhage from aneurysms and AVMs. 4, 5 They reported a grave AVM and aneurysm complication of pregnancy, which is responsible for 5-12% of all maternal deaths during pregnancy and 17% of fetal mortality. [4] [5] [6] [7] However, the small number of cases and bias of selected reports precluded a robust conclusion about their prevalence. Recommendations to avoid pregnancy, terminate pregnancy, or proceed with caesarean section rather than vaginal delivery are often queried by young women with potentially life-threatening AVMs. Most troubling is the absence of level 1 evidence on which we can draw in counselling these patients. To resolve this problem, this study was performed.
Methods
Between 2006 and 2010, 67 consecutive cases of AVM female patients were confirmed with pregnancy histories by telephone interview and were included and analysed in this study. This study has been approved by the ethics committee of our hospital. These patients'
Beijing Neurosurgical Institute, Beijing Tiantan Hospital, China ages at AVM diagnosis and at pregnancy, presentations, AVM treatment, obstetric histories, and clinical records were retrospectively reviewed and collected. The last pregnancy was the cut-off point. The AVMs were divided into prior to pregnancy (known AVM) and during/after pregnancy (unknown AVM) (Figure1). The risk of AVM haemorrhage for a new pregnancy was defined under these two conditions as well as obstetric considerations. The AVMs were classified by Spetzler-Martin grades (SMGs).
Statistical analysis
Statistical comparisons were performed using two-tailed t-tests for continuous data and 2 tests for categorical data. Haemorrhage rates were expressed as a percentage per pregnancy and 95% confidence intervals (CIs).
Results

Gravidas with known AVMs
There were 14 cases (20.9%) of known AVM prior to pregnancy, five had ruptured (35.7%) and nine unruptured (four seizures, two headaches, two neurological deficits and one incidental) (64.3%). These patients' ages at AVM diagnosis were 22.4 AE 7.8 years mean, and ranged from 6 to 30 years. Their ages at pregnancy were 28.1 AE 6.4 years mean, ranging from 24 to 33 years. There were four SMG II AVMs, nine SMG III AVMs and one SMG IV AVM. Three unruptured cases (one incidental, one headache and one seizure) were treated conservatively and another 11 cases, including five ruptured cases, were treated prior to pregnancy. The treatments for 11 cases were endovascular embolisation in 10 cases and surgery in one case. There was no AVM ruptured during pregnancy and abortion. Fourteen healthy babies were delivered by caesarean section in 12 pregnancies (85.7%) and vaginal delivery in two pregnancies (14.3%).
Gravidas with unknown AVMs
There were 53 unruptured AVMs undiagnosed prior to pregnancy, one bleeding developed at 38 weeks' gestation in 64 pregnancies, resulted a 1.6% (95% CI 0-4.6%) bleeding rate. This case was treated conservatively to full term and delivered a healthy baby by vaginal delivery. Sixty-four healthy babies were delivered by caesarean section in 11 pregnancies (17.2%) and vaginal delivery in 53 pregnancies (82.8%). Their ages at pregnancy were 26.9 AE 3.3 years mean, and ranged from 21 to 37 years. These patients at 37.6 AE 5.7 years of age, ranging from 24 to 59 years, were diagnosed with AVMs (28 ruptured (52.8%) and 25 unruptured (10 seizure, 10 headaches and five neurological deficits) (47.2%)). There were six SMG I AVMs, 18 SMG II AVMs, 19 SMG III AVMs, seven SMG IV AVMs and three SMG V AVMs.
Ruptured AVM during pregnancy
A 27-year-old primigravida had subarachnoid haemorrhage at 38 weeks' of gestation. She was conservatively controlled until term, with a good outcome accomplished by vaginal delivery. The SMG IV AVM in the cerebellar vermiform was confirmed by angiography after delivery and was successfully embolised with Onyx.
Statistical analysis
Compared with the known patients, the average age at first pregnancy (25.8 years vs. 28.1 years) and proportion of caesarean sections (17.2% vs. 85.7%) were lower for the unknown patients ( Table 1 ). The one haemorrhagic event that occurred during the 64 pregnancies in unknown patients gives a haemorrhagic event rate from an AVM during pregnancy of 1.6% (95% CI 0-4.6%). There was no difference between the haemorrhage rates of treated known and unknown AVMs during pregnancy (0 vs. 1.6%, P ¼ 0.791). Compared to caesarean section, vaginal delivery did not increase the risk of haemorrhage in unruptured AVM pregnancies (1.8% vs. 0, P ¼ 1.000).
Discussion
The data regarding AVM haemorrhage risk during pregnancy are inconclusive. By collecting AVM patients' obstetric history, we were able to evaluate the relationship of the AVM haemorrhage and pregnancy. By this approach, it appears that the haemorrhagic risk of treated known and unknown AVMs is not significantly increased during pregnancy, delivery, or postpartum. It is also interesting to note that no haemorrhagic events occurred during 14 pregnancies with known AVMs, including treated and untreated AVMs, and during two vaginal deliveries, 12 caesarean sections or the postpartum period. Compared with the known patients, the average age at first pregnancy (25.8 years vs. 28.1 years) and proportion of caesarean sections (17.2% vs. 85.7%) are significantly lower for those of unknown patients. These differences may be attributable to the knowledge that they are at increased risk of intracerebral haemorrhage compared with the general population. However, from our analysis, we do not believe that women with unruptured and treated ruptured AVMs should be advised to avoid, terminate a pregnancy or have a caesarean section. and the decision to undergo a caesarean section should be based on obstetric indications.
We do not recommend prophylactic surgical resection of unruptured AVMs for women considering pregnancy. However, prophylactic endovascular embolisation of unruptured AVMs with haemorrhagic predictors, such as coexisting aneurysm, fistula, deep location and venous drainage constriction, is recommended. Ruptured AVM is prone to re-rupture, the dynamic scenario of pregnancy probably increases the likelihood of this occurrence. 8, 9 In these cases, treatment prior to or during pregnancy is warranted. In our study, patients benefited from the treatment of ruptured pre-existing AVMs prior to pregnancies. Those women who become symptomatic during pregnancy or sustained intracerebral haemorrhage as a result of AVM rupture warrant treatment in an effort to preserve maternal and fetal health. These treatments, whether microsurgical, endovascular, or a combination of the two, can be performed.
Some studies also suggest that there is no correlation between the risk of AVM haemorrhage and pregnancy. [10] [11] [12] In a study of 451 patients who had 540 pregnancies, the incidence of haemorrhage was found to be 3.5% during the 52 weeks after the patient's last menstrual period. In patients with an AVM bleeding history before pregnancy, the incidence of rebleeding was 5.8% during the year after the last menstrual period. 13 Forster et al. 6 found 14 AVM bleedings in 211 full-term pregnancies, but none in 18 miscarriages. None of the women bled during labour, delivery, caesarean section and in the puerperium. This produces estimated risks of AVM rupture during pregnancy of 6.6%. 14 Fujita et al. have assessed the risks of pregnancy and delivery in the setting of maternal AVMs. The authors reported three symptomatic AVM haemorrhages in 46 pregnancies, yielding a rate of rupture of 6.5 AE 3.6% per pregnancy. 15 Liu et al. recently reported 12 AVM haemorrhages in 452 pregnancies, yielding an AVM bleeding rate of 2.65% per pregnancy. 16 These numbers are within the reported range of the natural history of AVMs in the general population. However, Gross and Du and Tonetti et al. have a slightly higher risks of AVM rupture during pregnancy and delivery. 14, 17 The authors reported five AVM haemorrhages in 62 pregnancies, resulting an 8.1% rate of rupture per pregnancy and two AVM haemorrhages in 18 pregnancies during the latency interval after stereotactic radiosurgery, resulting in an 11.1% rate of rupture per pregnancy. 14, 16 This percentage was higher than the reported range, but the small number of patients, the parts of ruptured and unruptured AVMs, and the effects of stereotactic radiosurgery will make the data non-definitive ( Table 2) . AVM bleeding occurs more frequently after the second trimester, when the blood volume and cardiac output reach their peak. The time of onset of AVM rupture may be related to the haemodynamic and hormonal change. 7 There is a selection bias in this study. Patients are from a wide referral base, and it would have been infeasible to obtain a complete set of obstetric records for all of the pregnancies included in the study. It is possible that haemorrhages occurred before the diagnosis of an AVM and went undetected. The obstetric data are based on self-reporting during a telephone interview. We have provided an overall estimate of the risk of haemorrhage during pregnancy from a diverse AVM population. We believe that gravidas with a diagnosis of AVM should be referred to a neurovascular team and counselled on their individual risk of haemorrhage.
Conclusion
Prior treatment for ruptured AVMs could prevent haemorrhage during pregnancy and the haemorrhage risk of unruptured AVMs in pregnancies is low. Although known AVM gravidas are prone to caesarean section, vaginal delivery seems not to increase the risk of haemorrhage in unknown AVM gravidas.
